SONOMA PHARMACEUTICALS, INC. Gain (Loss) on Extinguishment of Debt
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-06-21
- SONOMA PHARMACEUTICALS, INC. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- SONOMA PHARMACEUTICALS, INC. gain (loss) on extinguishment of debt for fiscal 2022 was $723.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|
| 2023-03-31 | $0.00 10-K · filed 2023-06-21 |
| 2022-03-31 | $723.00K 10-K · filed 2023-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |